The Diagnostic Value of Ischemia-modified Albumin in Prostate Cancer

Journal Title: The Medical Bulletin of Haseki - Year 2020, Vol 58, Issue 1

Abstract

Aim: The aim of this study was to investigate whether serum ischemia-modified albumin (IMA) levels have a diagnostic value in prostate cancer (Pca). Methods: Thirty primary Pca patients and 30 age-matched healthy male subjects were included in this prospective case-control study. The patients were selected from the urology clinic of a tertiary university hospital. Healthy men included in the control group were selected from hospital staff and patient relatives. Patients with severe chronic diseases and other malignancies were excluded. Serum IMA level was measured using the colorimetric method. The results were reported in absorbance unit (ABSU). Results: Serum IMA levels were significantly higher in the study group when compared to the control group (0.843±0.76 and 0.443±0.49 ABSU, respectively; p=0.002). The mean IMA value in patients with a Gleason score ≥7 (1.08±0.053 ABSU) was significantly higher than in patients with Gleason score ≤6 (IMA 0.418±0.64 ABSU). According to the receiving operating characteristic (ROC) analysis, when the cut-off value was ABSU=0.57, the sensitivity and specificity were 80% and 56.7%, respectively. Conclusion: Serum concentrations of IMA are significantly elevated especially in clinically significant Pca patients. Its high sensitivity (80%) in ROC analysis suggests that IMA can be used an ancillary biomarker in diagnosis.

Authors and Affiliations

Rahmi Aslan, Recep Eryılmaz, Mehmet Sevim, Murat Demir, Kerem Taken

Keywords

Related Articles

Factors that Increase the Need for Surgery in Chiari Malformation Type 1 Patients Morphometric Analyses in Chiari Patients

Aim: The causes of the syringomyelia in Chiari are not certainly defined. We have done morphometric analyses which can be useful to understand natural course and causes which increase the surgery requirement of patients....

Comparison of the Frequency and Severity of Depression Between Patients with Stage 4 and 5 Chronic Kidney Disease with and Without Kidney Transplantation

Aim: Patients with chronic kidney disease (CKD) are at an increased risk for depression. In the present study, we aimed to compare the frequency and severity of depression and its’ association with demographical and labo...

Fetal Biometry: Is it Same in African Population? Are There Racial Differences?

Aim: Our study aims to investigate whether there is a difference between the African pregnant population at 14-42 weeks of gestation and standard ultrasonographic fetal biometric measurements. Methods: This study was ca...

Do Inner Ear and Mastoid Bone Structural Variations Have a Determining Role on Vestibular Symptoms of Migraine?

Aim: To investigate the possible relationship between morphological changes caused by anatomical structural differences and functional impairment in Vestibular migraine (VM) and Chronic Migraine (CM) disease. Methods: A...

The Effect of Autosomal Dominant Polycystic Kidney Disease on Spirometric Parameters

Aim: There is no enough data on pulmonary involvement in autosomal dominant polycystic kidney disease (ADPKD). The aim of this study is to examine pulmonary function test in patients with ADPKD with varying stages of ren...

Download PDF file
  • EP ID EP685253
  • DOI 10.4274/haseki.galenos.2019.5416
  • Views 119
  • Downloads 0

How To Cite

Rahmi Aslan, Recep Eryılmaz, Mehmet Sevim, Murat Demir, Kerem Taken (2020). The Diagnostic Value of Ischemia-modified Albumin in Prostate Cancer. The Medical Bulletin of Haseki, 58(1), -. https://europub.co.uk/articles/-A-685253